PERSPECTIVE THERAPEUTICS, INC. Investment Warrants, Exercise Price
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Investment Warrants, Exercise Price of $0.95 for the 1-month period ending 2010-10-20, per its 10-K/A filed 2012-10-26.
Discontinued › Notes
invest:InvestmentWarrantsExercisePrice · last filed 2012-10-26
- 2010-10-20: Investment Warrants, Exercise Price 1 month $0.95.
| Period end | Investment Warrants, Exercise Price 1 month |
|---|---|
| 2010-10-20 | $0.95 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |